PSP is beneficial in HFD-induced obese rats, as it improves hyperlipidemia, decreases BW, hepatic malondialdehyde, and inflammatory cytokine levels, and increases the hepatic catalase and superoxide dismutase activities [15]. This evidence concerns the gene CAT and hyperlipidemia.